The Vpu Protein: New Concepts in Virus Release and CD4 Down-modulation

Overview

Journal Curr HIV Res

Publisher Bentham Science Publishers

Date 2010 Mar 6

PMID 20201792

Citations 19

Authors

Autumn Ruiz

John C Guatelli

Edward B Stephens

Affiliations

Soon will be listed here.

Abstract

Human immunodeficiency virus type 1 (HIV-1) and several simian immunodeficiency viruses (SIV) encode for a transmembrane protein known as Vpu (viral protein U). While one of the smallest of the HIV-1 proteins, it has two important functions within virus-infected cells. The first of these functions is the down-regulation of the CD4 receptor to prevent its interaction with the HIV-1 envelope glycoprotein. Vpu interacts with the CD4 receptor in the rough endoplasmic reticulum (RER), resulting in its re-translocation across the RER and subsequent degradation via the proteasomal pathway. The second major function of the Vpu protein is to facilitate release of virus from infected cells. Previous studies have shown that virus release is cell type specific, suggesting that certain cells may express a restriction factor that inhibits virus release in the absence of Vpu. Recently, bone marrow stromal antigen 2 (BST-2/HM1.24/CD317/tetherin) has been identified as this factor. This review will focus on new findings within the last four years on the role of Vpu in CD4 down-regulation and the restriction of virus release from cells. We will relate these findings to virus pathogenesis and propose questions regarding BST-2 as a restriction factor.

Citing Articles

Downregulation of endogenous nectin1 in human keratinocytes by herpes simplex virus 1 glycoprotein D excludes superinfection but does not affect NK cell function.

Kite J, Hill M, Preston N, Rubina A, Kollnberger S, Wang E J Gen Virol. 2024; 105(3).

PMID: 38471041 PMC: 10950026. DOI: 10.1099/jgv.0.001969.

HIV-1 virological synapse formation enhances infection spread by dysregulating Aurora Kinase B.

Bruce J, Park E, Magnano C, Horswill M, Richards A, Potts G PLoS Pathog. 2023; 19(7):e1011492.

PMID: 37459363 PMC: 10374047. DOI: 10.1371/journal.ppat.1011492.

The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1).

Henke W, Waisner H, Arachchige S, Kalamvoki M, Stephens E Retrovirology. 2022; 19(1):25.

PMID: 36403071 PMC: 9675205. DOI: 10.1186/s12977-022-00611-6.

Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2.

Breitinger U, Farag N, Sticht H, Breitinger H Int J Biochem Cell Biol. 2022; 145:106185.

PMID: 35219876 PMC: 8868010. DOI: 10.1016/j.biocel.2022.106185.

HIV-1 Impairment via UBE3A and HIV-1 Nef Interactions Utilizing the Ubiquitin Proteasome System.

Pyeon D, Rojas V, Price L, Kim S, Meharvan S, Park I Viruses. 2019; 11(12).

PMID: 31783587 PMC: 6950590. DOI: 10.3390/v11121098.

References

Hout D, Gomez L, Pacyniak E, Miller J, Hill M, Stephens E . A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine. Virology. 2006; 348(2):449-61. DOI: 10.1016/j.virol.2005.12.025. View

Barlow K, Ajao A, Clewley J . Characterization of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona). J Virol. 2003; 77(12):6879-88. PMC: 156208. DOI: 10.1128/jvi.77.12.6879-6888.2003. View

Ishikawa J, Kaisho T, Tomizawa H, Lee B, Kobune Y, Inazawa J . Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics. 1995; 26(3):527-34. DOI: 10.1016/0888-7543(95)80171-h. View

Bartee E, McCormack A, Fruh K . Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2007; 2(10):e107. PMC: 1626102. DOI: 10.1371/journal.ppat.0020107. View

Park S, Opella S . Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs. Protein Sci. 2007; 16(10):2205-15. PMC: 2204142. DOI: 10.1110/ps.073041107. View

Schubert U, Henklein P, Boldyreff B, Wingender E, Strebel K, Porstmann T . The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J Mol Biol. 1994; 236(1):16-25. DOI: 10.1006/jmbi.1994.1114. View

Wray V, Kinder R, Federau T, Henklein P, Bechinger B, Schubert U . Solution structure and orientation of the transmembrane anchor domain of the HIV-1-encoded virus protein U by high-resolution and solid-state NMR spectroscopy. Biochemistry. 1999; 38(16):5272-82. DOI: 10.1021/bi982755c. View

Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, Banting G . Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic. 2003; 4(10):694-709. DOI: 10.1034/j.1600-0854.2003.00129.x. View

Van Damme N, Goff D, Katsura C, Jorgenson R, Mitchell R, Johnson M . The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe. 2008; 3(4):245-52. PMC: 2474773. DOI: 10.1016/j.chom.2008.03.001. View

10.

Gummuluru S, Kinsey C, Emerman M . An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus. J Virol. 2000; 74(23):10882-91. PMC: 113167. DOI: 10.1128/jvi.74.23.10882-10891.2000. View

11.

Schubert U, Ferrer-Montiel A, Henklein P, Strebel K, Montal M . Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 1996; 398(1):12-8. DOI: 10.1016/s0014-5793(96)01146-5. View

12.

Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana I . Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 2009; 5(5):e1000429. PMC: 2673686. DOI: 10.1371/journal.ppat.1000429. View

13.

McNatt M, Zang T, Hatziioannou T, Bartlett M, Fofana I, Johnson W . Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 2009; 5(2):e1000300. PMC: 2633611. DOI: 10.1371/journal.ppat.1000300. View

14.

Megy S, Bertho G, Gharbi-Benarous J, Evrard-Todeschi N, Coadou G, Segeral E . STD and TRNOESY NMR studies on the conformation of the oncogenic protein beta-catenin containing the phosphorylated motif DpSGXXpS bound to the beta-TrCP protein. J Biol Chem. 2005; 280(32):29107-16. DOI: 10.1074/jbc.M501628200. View

15.

Rong L, Zhang J, Lu J, Pan Q, Lorgeoux R, Aloysius C . The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J Virol. 2009; 83(15):7536-46. PMC: 2708638. DOI: 10.1128/JVI.00620-09. View

16.

Besnard-Guerin C, Belaidouni N, Lassot I, Segeral E, Jobart A, Marchal C . HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates. J Biol Chem. 2003; 279(1):788-95. DOI: 10.1074/jbc.M308068200. View

17.

Buonocore L, Turi T, Crise B, Rose J . Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology. 1994; 204(1):482-6. DOI: 10.1006/viro.1994.1560. View

18.

Tang Y, Zaitseva F, Lamb R, Pinto L . The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue. J Biol Chem. 2002; 277(42):39880-6. DOI: 10.1074/jbc.M206582200. View

19.

Willey R, Maldarelli F, Martin M, Strebel K . Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol. 1992; 66(12):7193-200. PMC: 240416. DOI: 10.1128/JVI.66.12.7193-7200.1992. View

20.

Grice A, Kerr I, Sansom M . Ion channels formed by HIV-1 Vpu: a modelling and simulation study. FEBS Lett. 1997; 405(3):299-304. DOI: 10.1016/s0014-5793(97)00198-1. View